Iminourea en es it fr

Iminourea Brand names, Iminourea Analogs

Iminourea Brand Names Mixture

  • No information avaliable

Iminourea Chemical_Formula


Iminourea RX_link

No information avaliable

Iminourea fda sheet

Iminourea msds (material safety sheet)

Iminourea MSDS

Iminourea Synthesis Reference

No information avaliable

Iminourea Molecular Weight

59.0706 g/mol

Iminourea Melting Point

183 oC (HCl salt)

Iminourea H2O Solubility

500 mg/mL (HCl salt)

Iminourea State


Iminourea LogP


Iminourea Dosage Forms

No information avaliable

Iminourea Indication

For the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis.

Iminourea Pharmacology

Guanidine apparently acts by enhancing the release of acetylcholine following a nerve impulse. It also appears to slow the rates of depolarization and repolarization of muscle cell membranes.

Iminourea Absorption

Rapidly absorbed and distributed

Iminourea side effects and Toxicity

LD50 = 475 mg/kg (oral, rat). Can cause severe gastrointestinal symptoms (nausea, vomiting and diarrhea), bone marrow suppression, renal insufficiency and other hematologic abnormalities (anemia, leucopenia). Severe guanidine intoxication is characterized by nervous hyperirritability, fibrillary tremors and convulsive contractions of muscle, salivation, vomiting, diarrhea, hypoglycemia, and circulatory disturbances.

Iminourea Patient Information

No information avaliable

Iminourea Organisms Affected

Humans and other mammals